| # | Title | Journal | Year | Citations |
|---|
| 1 | The rand 36-item health survey 1.0 | Health Economics (United Kingdom) | 1993 | 2,292 |
| 2 | Discrete choice experiments in health economics: a review of the literature | Health Economics (United Kingdom) | 2012 | 924 |
| 3 | Representing uncertainty: the role of cost-effectiveness acceptability curves | Health Economics (United Kingdom) | 2001 | 885 |
| 4 | Valuing health-related quality of life: An EQ-5D-5L value set for England | Health Economics (United Kingdom) | 2018 | 863 |
| 5 | Costs, effects and C/E-ratios alongside a clinical trial | Health Economics (United Kingdom) | 1994 | 825 |
| 6 | Catastrophe and impoverishment in paying for health care: with applications to Vietnam 1993-1998 | Health Economics (United Kingdom) | 2003 | 791 |
| 7 | Cost-effectiveness acceptability curves– facts, fallacies and frequently asked questions | Health Economics (United Kingdom) | 2004 | 754 |
| 8 | Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility | Health Economics (United Kingdom) | 2005 | 750 |
| 9 | A comparison of the EQ-5D and SF-6D across seven patient groups | Health Economics (United Kingdom) | 2004 | 680 |
| 10 | Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis | Health Economics (United Kingdom) | 2004 | 609 |
| 11 | The measurement of efficiency and productivity of health care delivery | Health Economics (United Kingdom) | 2008 | 585 |
| 12 | The time trade-off method: Results from a general population study | Health Economics (United Kingdom) | 1996 | 579 |
| 13 | Review of statistical methods for analysing healthcare resources and costs | Health Economics (United Kingdom) | 2011 | 574 |
| 14 | International survey on willingness‐to‐pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness? | Health Economics (United Kingdom) | 2010 | 560 |
| 15 | Why health equity? | Health Economics (United Kingdom) | 2002 | 532 |
| 16 | Explaining income-related inequalities in doctor utilisation in Europe | Health Economics (United Kingdom) | 2004 | 512 |
| 17 | The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies | Health Economics (United Kingdom) | 2006 | 494 |
| 18 | The bounds of the concentration index when the variable of interest is binary, with an application to immunization inequality | Health Economics (United Kingdom) | 2005 | 490 |
| 19 | Uncertainty in the economic evaluation of health care technologies: The role of sensitivity analysis | Health Economics (United Kingdom) | 1994 | 487 |
| 20 | Estimating an EQ-5D population value set: the case of Japan | Health Economics (United Kingdom) | 2002 | 472 |
| 21 | Catastrophic payments for health care in Asia | Health Economics (United Kingdom) | 2007 | 459 |
| 22 | Something old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost-effectiveness analysis | Health Economics (United Kingdom) | 2002 | 435 |
| 23 | A taxonomy of model structures for economic evaluation of health technologies | Health Economics (United Kingdom) | 2006 | 429 |
| 24 | Effects coding in discrete choice experiments | Health Economics (United Kingdom) | 2005 | 425 |
| 25 | A comparison of approaches to estimating confidence intervals for willingness to pay measures | Health Economics (United Kingdom) | 2007 | 410 |
| 26 | True health vs response styles: exploring cross-country differences in self-reported health | Health Economics (United Kingdom) | 2007 | 407 |
| 27 | Using qualitative methods for attribute development for discrete choice experiments: issues and recommendations | Health Economics (United Kingdom) | 2012 | 395 |
| 28 | The death of cost-minimization analysis? | Health Economics (United Kingdom) | 2001 | 377 |
| 29 | Explaining the differences in income-related health inequalities across European countries | Health Economics (United Kingdom) | 2004 | 372 |
| 30 | Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra | Health Economics (United Kingdom) | 2005 | 368 |
| 31 | The New Cooperative Medical Scheme in rural China: does more coverage mean more service and better health? | Health Economics (United Kingdom) | 2009 | 353 |
| 32 | Distinguishing between heterogeneity and inefficiency: stochastic frontier analysis of the World Health Organization's panel data on national health care systems | Health Economics (United Kingdom) | 2004 | 345 |
| 33 | The wage effects of obesity: a longitudinal study | Health Economics (United Kingdom) | 2004 | 344 |
| 34 | Theory versuspractice: a review of ?willingness-to-pay? in health and health care | Health Economics (United Kingdom) | 2001 | 340 |
| 35 | Health service delivery in China: a literature review | Health Economics (United Kingdom) | 2008 | 338 |
| 36 | Cigarette demand: a meta-analysis of elasticities | Health Economics (United Kingdom) | 2003 | 335 |
| 37 | QALY maximisation and people's preferences: a methodological review of the literature | Health Economics (United Kingdom) | 2005 | 324 |
| 38 | Unemployment and self‐assessed health: evidence from panel data | Health Economics (United Kingdom) | 2009 | 312 |
| 39 | Informal and formal care among single‐living elderly in Europe | Health Economics (United Kingdom) | 2008 | 311 |
| 40 | Socioeconomic status, depression disparities, and financial strain: what lies behind the income-depression relationship? | Health Economics (United Kingdom) | 2005 | 309 |
| 41 | Whither trial-based economic evaluation for health care decision making? | Health Economics (United Kingdom) | 2006 | 302 |
| 42 | Regression methods for covariate adjustment and subgroup analysis for non-censored cost-effectiveness data | Health Economics (United Kingdom) | 2004 | 285 |
| 43 | Deleting ‘irrational’ responses from discrete choice experiments: a case of investigating or imposing preferences? | Health Economics (United Kingdom) | 2006 | 281 |
| 44 | Missing.... presumed at random: cost-analysis of incomplete data | Health Economics (United Kingdom) | 2003 | 280 |
| 45 | The impact of price regulation on the launch delay of new drugs?evidence from twenty-five major markets in the 1990s | Health Economics (United Kingdom) | 2005 | 275 |
| 46 | Design techniques for stated preference methods in health economics | Health Economics (United Kingdom) | 2003 | 256 |
| 47 | Adolescent depression: diagnosis, treatment, and educational attainment | Health Economics (United Kingdom) | 2008 | 254 |
| 48 | Definition, interpretation and calculation of cost-effectiveness acceptability curves | Health Economics (United Kingdom) | 2000 | 253 |
| 49 | Does reporting heterogeneity bias the measurement of health disparities? | Health Economics (United Kingdom) | 2008 | 243 |
| 50 | Population ageing and health care expenditure: a school of ‘red herrings’? | Health Economics (United Kingdom) | 2007 | 240 |
